1 Market Overview of Eisenmenger Syndrome Treatment 1.1 Eisenmenger Syndrome Treatment Market Overview 1.1.1 Eisenmenger Syndrome Treatment Product Scope 1.1.2 Eisenmenger Syndrome Treatment Market Status and Outlook 1.2 Global Eisenmenger Syndrome Treatment Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Eisenmenger Syndrome Treatment Market Size by Region (2016-2027) 1.4 Global Eisenmenger Syndrome Treatment Historic Market Size by Region (2016-2021) 1.5 Global Eisenmenger Syndrome Treatment Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Eisenmenger Syndrome Treatment Market Size (2016-2027) 1.6.1 North America Eisenmenger Syndrome Treatment Market Size (2016-2027) 1.6.2 Europe Eisenmenger Syndrome Treatment Market Size (2016-2027) 1.6.3 Asia-Pacific Eisenmenger Syndrome Treatment Market Size (2016-2027) 1.6.4 Latin America Eisenmenger Syndrome Treatment Market Size (2016-2027) 1.6.5 Middle East & Africa Eisenmenger Syndrome Treatment Market Size (2016-2027) 2 Eisenmenger Syndrome Treatment Market Overview by Drug Type 2.1 Global Eisenmenger Syndrome Treatment Market Size by Drug Type: 2016 VS 2021 VS 2027 2.2 Global Eisenmenger Syndrome Treatment Historic Market Size by Drug Type (2016-2021) 2.3 Global Eisenmenger Syndrome Treatment Forecasted Market Size by Drug Type (2022-2027) 2.4 Antiarrhythmic Agents 2.5 Blood Thinning Agents 2.6 Endothelin Receptor Antagonist 2.7 Others 3 Eisenmenger Syndrome Treatment Market Overview by Diagnosis 3.1 Global Eisenmenger Syndrome Treatment Market Size by Diagnosis: 2016 VS 2021 VS 2027 3.2 Global Eisenmenger Syndrome Treatment Historic Market Size by Diagnosis (2016-2021) 3.3 Global Eisenmenger Syndrome Treatment Forecasted Market Size by Diagnosis (2022-2027) 3.4 Blood tests 3.5 Electrocardiogram (ECG) 3.6 Chest X-ray 3.7 Echocardiogram 3.8 Computerized tomography (CT) scan 3.9 Magnetic resonance imaging (MRI) 3.10 Cardiac catheterization 3.11 Walking test 4 Eisenmenger Syndrome Treatment Competition Analysis by Players 4.1 Global Eisenmenger Syndrome Treatment Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eisenmenger Syndrome Treatment as of 2020) 4.3 Date of Key Players Enter into Eisenmenger Syndrome Treatment Market 4.4 Global Top Players Eisenmenger Syndrome Treatment Headquarters and Area Served 4.5 Key Players Eisenmenger Syndrome Treatment Product Solution and Service 4.6 Competitive Status 4.6.1 Eisenmenger Syndrome Treatment Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Actelion Pharmaceuticals Ltd. 5.1.1 Actelion Pharmaceuticals Ltd. Profile 5.1.2 Actelion Pharmaceuticals Ltd. Main Business 5.1.3 Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Products, Services and Solutions 5.1.4 Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.1.5 Actelion Pharmaceuticals Ltd. Recent Developments 5.2 Gilead Sciences, Inc. 5.2.1 Gilead Sciences, Inc. Profile 5.2.2 Gilead Sciences, Inc. Main Business 5.2.3 Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Products, Services and Solutions 5.2.4 Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.2.5 Gilead Sciences, Inc. Recent Developments 5.3 Pfizer, Inc. 5.5.1 Pfizer, Inc. Profile 5.3.2 Pfizer, Inc. Main Business 5.3.3 Pfizer, Inc. Eisenmenger Syndrome Treatment Products, Services and Solutions 5.3.4 Pfizer, Inc. Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.3.5 Teva Pharmaceutical Industries Ltd. Recent Developments 5.4 Teva Pharmaceutical Industries Ltd. 5.4.1 Teva Pharmaceutical Industries Ltd. Profile 5.4.2 Teva Pharmaceutical Industries Ltd. Main Business 5.4.3 Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Products, Services and Solutions 5.4.4 Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.4.5 Teva Pharmaceutical Industries Ltd. Recent Developments 5.5 AstraZeneca plc. 5.5.1 AstraZeneca plc. Profile 5.5.2 AstraZeneca plc. Main Business 5.5.3 AstraZeneca plc. Eisenmenger Syndrome Treatment Products, Services and Solutions 5.5.4 AstraZeneca plc. Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.5.5 AstraZeneca plc. Recent Developments 5.6 Novartis AG 5.6.1 Novartis AG Profile 5.6.2 Novartis AG Main Business 5.6.3 Novartis AG Eisenmenger Syndrome Treatment Products, Services and Solutions 5.6.4 Novartis AG Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.6.5 Novartis AG Recent Developments 5.7 Merck & Co., Inc. 5.7.1 Merck & Co., Inc. Profile 5.7.2 Merck & Co., Inc. Main Business 5.7.3 Merck & Co., Inc. Eisenmenger Syndrome Treatment Products, Services and Solutions 5.7.4 Merck & Co., Inc. Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.7.5 Merck & Co., Inc. Recent Developments 5.8 GlaxoSmithKline plc. 5.8.1 GlaxoSmithKline plc. Profile 5.8.2 GlaxoSmithKline plc. Main Business 5.8.3 GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Products, Services and Solutions 5.8.4 GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.8.5 GlaxoSmithKline plc. Recent Developments 5.9 Mylan N.V. 5.9.1 Mylan N.V. Profile 5.9.2 Mylan N.V. Main Business 5.9.3 Mylan N.V. Eisenmenger Syndrome Treatment Products, Services and Solutions 5.9.4 Mylan N.V. Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.9.5 Mylan N.V. Recent Developments 5.10 Bayer AG 5.10.1 Bayer AG Profile 5.10.2 Bayer AG Main Business 5.10.3 Bayer AG Eisenmenger Syndrome Treatment Products, Services and Solutions 5.10.4 Bayer AG Eisenmenger Syndrome Treatment Revenue (US$ Million) & (2016-2021) 5.10.5 Bayer AG Recent Developments 6 North America 6.1 North America Eisenmenger Syndrome Treatment Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Eisenmenger Syndrome Treatment Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Eisenmenger Syndrome Treatment Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Eisenmenger Syndrome Treatment Market Dynamics 11.1 Eisenmenger Syndrome Treatment Industry Trends 11.2 Eisenmenger Syndrome Treatment Market Drivers 11.3 Eisenmenger Syndrome Treatment Market Challenges 11.4 Eisenmenger Syndrome Treatment Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Eisenmenger Syndrome Treatment Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Eisenmenger Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Eisenmenger Syndrome Treatment Market Size Share by Region (2016-2021) Table 4. Global Eisenmenger Syndrome Treatment Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Eisenmenger Syndrome Treatment Forecasted Market Size Share by Region (2022-2027) Table 6. Global Eisenmenger Syndrome Treatment Market Size (US$ Million) by Drug Type: 2016 VS 2021 VS 2027 Table 7. Global Eisenmenger Syndrome Treatment Market Size by Drug Type (2016-2021) & (US$ Million) Table 8. Global Eisenmenger Syndrome Treatment Revenue Market Share by Drug Type (2016-2021) Table 9. Global Eisenmenger Syndrome Treatment Forecasted Market Size by Drug Type (2022-2027) & (US$ Million) Table 10. Global Eisenmenger Syndrome Treatment Revenue Market Share by Drug Type (2022-2027) Table 11. Global Eisenmenger Syndrome Treatment Market Size (US$ Million) by Diagnosis: 2016 VS 2021 VS 2027 Table 12. Global Eisenmenger Syndrome Treatment Market Size by Diagnosis (2016-2021) & (US$ Million) Table 13. Global Eisenmenger Syndrome Treatment Revenue Market Share by Diagnosis (2016-2021) Table 14. Global Eisenmenger Syndrome Treatment Forecasted Market Size by Diagnosis (2022-2027) & (US$ Million) Table 15. Global Eisenmenger Syndrome Treatment Revenue Market Share by Diagnosis (2022-2027) Table 16. Global Eisenmenger Syndrome Treatment Revenue (US$ Million) by Players (2016-2021) Table 17. Global Eisenmenger Syndrome Treatment Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Eisenmenger Syndrome Treatment as of 2020) Table 19. Date of Key Manufacturers Enter into Eisenmenger Syndrome Treatment Market Table 20. Global Eisenmenger Syndrome Treatment Top Players Headquarters and Area Served Table 21. Eisenmenger Syndrome Treatment Product Solution and Service Table 22. Global Eisenmenger Syndrome Treatment Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Actelion Pharmaceuticals Ltd. Basic Information List Table 25. Actelion Pharmaceuticals Ltd. Description and Business Overview Table 26. Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Products, Services and Solutions Table 27. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of Actelion Pharmaceuticals Ltd. (2016-2021) Table 28. Actelion Pharmaceuticals Ltd. Recent Developments Table 29. Gilead Sciences, Inc. Basic Information List Table 30. Gilead Sciences, Inc. Description and Business Overview Table 31. Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Products, Services and Solutions Table 32. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of Gilead Sciences, Inc. (2016-2021) Table 33. Gilead Sciences, Inc. Recent Developments Table 34. Pfizer, Inc. Basic Information List Table 35. Pfizer, Inc. Description and Business Overview Table 36. Pfizer, Inc. Eisenmenger Syndrome Treatment Products, Services and Solutions Table 37. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of Pfizer, Inc. (2016-2021) Table 38. Pfizer, Inc. Recent Developments Table 39. Teva Pharmaceutical Industries Ltd. Basic Information List Table 40. Teva Pharmaceutical Industries Ltd. Description and Business Overview Table 41. Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Products, Services and Solutions Table 42. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of Teva Pharmaceutical Industries Ltd. (2016-2021) Table 43. Teva Pharmaceutical Industries Ltd. Recent Developments Table 44. AstraZeneca plc. Basic Information List Table 45. AstraZeneca plc. Description and Business Overview Table 46. AstraZeneca plc. Eisenmenger Syndrome Treatment Products, Services and Solutions Table 47. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of AstraZeneca plc. (2016-2021) Table 48. AstraZeneca plc. Recent Developments Table 49. Novartis AG Basic Information List Table 50. Novartis AG Description and Business Overview Table 51. Novartis AG Eisenmenger Syndrome Treatment Products, Services and Solutions Table 52. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of Novartis AG (2016-2021) Table 53. Novartis AG Recent Developments Table 54. Merck & Co., Inc. Basic Information List Table 55. Merck & Co., Inc. Description and Business Overview Table 56. Merck & Co., Inc. Eisenmenger Syndrome Treatment Products, Services and Solutions Table 57. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of Merck & Co., Inc. (2016-2021) Table 58. Merck & Co., Inc. Recent Developments Table 59. GlaxoSmithKline plc. Basic Information List Table 60. GlaxoSmithKline plc. Description and Business Overview Table 61. GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Products, Services and Solutions Table 62. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of GlaxoSmithKline plc. (2016-2021) Table 63. GlaxoSmithKline plc. Recent Developments Table 64. Mylan N.V. Basic Information List Table 65. Mylan N.V. Description and Business Overview Table 66. Mylan N.V. Eisenmenger Syndrome Treatment Products, Services and Solutions Table 67. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of Mylan N.V. (2016-2021) Table 68. Mylan N.V. Recent Developments Table 69. Bayer AG Basic Information List Table 70. Bayer AG Description and Business Overview Table 71. Bayer AG Eisenmenger Syndrome Treatment Products, Services and Solutions Table 72. Revenue (US$ Million) in Eisenmenger Syndrome Treatment Business of Bayer AG (2016-2021) Table 73. Bayer AG Recent Developments Table 74. North America Eisenmenger Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million) Table 75. North America Eisenmenger Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe Eisenmenger Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe Eisenmenger Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific Eisenmenger Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific Eisenmenger Syndrome Treatment Market Share by Region (2016-2021) Table 81. Asia-Pacific Eisenmenger Syndrome Treatment Market Share by Region (2022-2027) Table 82. Latin America Eisenmenger Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America Eisenmenger Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa Eisenmenger Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million) Table 86. Eisenmenger Syndrome Treatment Market Trends Table 87. Eisenmenger Syndrome Treatment Market Drivers Table 88. Eisenmenger Syndrome Treatment Market Challenges Table 89. Eisenmenger Syndrome Treatment Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global Eisenmenger Syndrome Treatment Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Eisenmenger Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Eisenmenger Syndrome Treatment Market Share by Regions: 2021 VS 2027 Figure 4. Global Eisenmenger Syndrome Treatment Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Eisenmenger Syndrome Treatment Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Eisenmenger Syndrome Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Eisenmenger Syndrome Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Eisenmenger Syndrome Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Eisenmenger Syndrome Treatment Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Eisenmenger Syndrome Treatment Market Size Share by Drug Type in 2021 & 2027 Figure 11. Antiarrhythmic Agents Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. Blood Thinning Agents Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Endothelin Receptor Antagonist Market Size (US$ Million) YoY Growth (2016-2027) Figure 14. Others Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Global Eisenmenger Syndrome Treatment Market Size Share by Diagnosis in 2021 & 2027 Figure 16. Blood tests Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Electrocardiogram (ECG) Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Chest X-ray Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Echocardiogram Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Computerized tomography (CT) scan Market Size (US$ Million) YoY Growth (2016-2027) Figure 21. Magnetic resonance imaging (MRI) Market Size (US$ Million) YoY Growth (2016-2027) Figure 22. Eisenmenger Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 23. Global Top 5 and Top 10 Players Eisenmenger Syndrome Treatment Market Share in 2020 Figure 24. North America Eisenmenger Syndrome Treatment Market Share by Country (2016-2027) Figure 25. United States Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 26. Canada Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 27. Germany Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 28. France Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 29. U.K. Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 30. Italy Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 31. Russia Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 32. Nordic Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 33. Rest of Europe Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 34. Asia-Pacific Eisenmenger Syndrome Treatment Market Share by Region (2016-2027) Figure 35. China Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 36. Japan Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 37. South Korea Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 38. Southeast Asia Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 39. India Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 40. Australia Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 41. Rest of Asia-Pacific Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 42. Latin America Eisenmenger Syndrome Treatment Market Share by Country (2016-2027) Figure 43. Mexico Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 44. Brazil Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 45. Rest of Latin America Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 46. Middle East & Africa Eisenmenger Syndrome Treatment Market Share by Country (2016-2027) Figure 47. Turkey Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 48. Saudi Arabia Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 49. UAE Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 50. Rest of Middle East & Africa Eisenmenger Syndrome Treatment Market Size (2016-2027) & (US$ Million) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation

Actelion Pharmaceuticals Ltd. Gilead Sciences, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. AstraZeneca plc. Novartis AG Merck & Co., Inc. GlaxoSmithKline plc. Mylan N.V. Bayer AG